Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Macedo Sanches Fernandes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Stem Cell Research & Therapy|August 7, 2025
Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled studyJoyce Macedo Sanches Fernandes, Eduardo Pagani, Cristiane Valverde Wenceslau, et al.
Frontiers in Genetics|July 9, 2024
How does the age of control individuals hinder the identification of target genes for Huntington's disease?João Rafael Dias Pinto, Benedito Faustinoni Neto, Joyce Macedo Sanches Fernandes, et al.
Stem Cell Research & Therapy|November 4, 2025
A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's diseaseJoyce Macedo Sanches Fernandes, Eduardo Pagani, Cristiane Valverde Wenceslau, et al.
Journal of Neurology|December 12, 2024
Tract-specific spinal damage in SCA2, SCA3 and SCA6Fabrício Castro de Borba, Joyce Macedo Sanches Fernandes, Thiago Junqueira Ribeiro de Rezende, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Stem Cell Research & Therapy|August 7, 2025
Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled studyJoyce Macedo Sanches Fernandes, Eduardo Pagani, Cristiane Valverde Wenceslau, et al.
Frontiers in Genetics|July 9, 2024
How does the age of control individuals hinder the identification of target genes for Huntington's disease?João Rafael Dias Pinto, Benedito Faustinoni Neto, Joyce Macedo Sanches Fernandes, et al.
Stem Cell Research & Therapy|November 4, 2025
A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's diseaseJoyce Macedo Sanches Fernandes, Eduardo Pagani, Cristiane Valverde Wenceslau, et al.
Journal of Neurology|December 12, 2024
Tract-specific spinal damage in SCA2, SCA3 and SCA6Fabrício Castro de Borba, Joyce Macedo Sanches Fernandes, Thiago Junqueira Ribeiro de Rezende, et al.
Pageof 1